menu
    • menu

    Company profile for Immunomedics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunomedics is deeply committed to becoming the leading antibody drug conjugate (ADC) company worldwide, delivering breakthrough therapies to treat complex cancers and transform patient outcomes.Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunomedicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 The American Road Morris Plains, NJ 07950
    Telephone
    Telephone
    (973) 605-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunomedics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunomedics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunomedicsinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Former Immunomedics CFO pleads guilty to securities fraud
    Former Immunomedics CFO pleads guilty to securities fraud

    18 May 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/former-immunomedics-cfo-pleads-guilty-securities-fraud-over-trodelvy-tip

    Annalee Armstrong FIERCE BIOTECH
    18 May 2023
    Share Share
    Immunomedics' Biologic Trodelvy ( Sacituzumab Govitecan) Receives Approval in the U.S.
    Immunomedics' Biologic Trodelvy ( Sacituzumab Govitecan) Receives Approval in the U.S.

    03 Feb 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761115

    FDA
    03 Feb 2023
    Share Share
    Girlfriend of ex-Immunomedics CFO pleads guilty to fraud
    Girlfriend of ex-Immunomedics CFO pleads guilty to fraud

    24 Jun 2022

    // Paul Schloesser ENDPTS

    https://endpts.com/ex-girlfriend-of-former-immunomedics-exec-usama-malik-pleads-guilty-in-insider-trading-scheme/

    Paul Schloesser ENDPTS
    24 Jun 2022
    Share Share
    Immunomedics`s Trodelvy (Sacituzumab Govitecan) Receives Approval the U.S.
    Immunomedics`s Trodelvy (Sacituzumab Govitecan) Receives Approval the U.S.

    03 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761115

    FDA
    03 Jun 2022
    Share Share
    Former Immunomedics CFO indicted on insider trading charges
    Former Immunomedics CFO indicted on insider trading charges

    12 May 2022

    // G. Masson FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/former-immunomedics-cfo-malik-indicted-insider-trading-case-heads-closer-trial

    G. Masson FIERCEBIOTECH
    12 May 2022
    Share Share
    Immunomedics will settle claims it misrepresented Trodelvy data
    Immunomedics will settle claims it misrepresented Trodelvy data

    19 Apr 2022

    // F. Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/gileads-immunomedics-floats-4m-put-asco-fiasco-bed

    F. Kansteiner FIERCEPHARMA
    19 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Contact Immunomedics and get a quotation

    Immunomedics is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of MURINE MONOCLONAL ANTIBODY (IMM-LL-2) TO B-CELL LYMPHOMA AND LEUKEMIA CELLS bulk offered by Immunomedics

    Find a price of MURINE MONOCLONAL ANTIBODY (IMMU-31) TO ALPHA-FETOPROTEIN bulk offered by Immunomedics

    Find a price of MURINE MONOCLONAL ANTIBODY AND F(AB)2 FRAGMENT (IMMU-14) TO CARCINOEMBRYONIC ANTIGEN (CEA) bulk offered by Immunomedics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search